全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1039931-72-0 | Tetrahydro-4-(2-methoxyphenyl)-2H-pyran-4-carboxylic acid | C13H16O4 |
| 1039932-36-9 | 1-(4-Bromophenyl)cyclobutanemethanamine | C11H14BrN |
| 1039948-89-4 | 4-(2-Hydroxyethoxy)-3,5-dimethylbenzaldehyde | C11H14O3 |
| 1040085-98-0 | Budesonide EP Impurity B;(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | C23H30O6 |
| 1040276-87-6 | 4-Bromo-3,5-dimethylpyrazole-1-carboxylic acid tert-butyl ester | C10H15BrN2O2 |
| 1040281-97-7 | 3-Chlorothiophene-2-boronic acid pinacol ester | C10H14BClO2S |
| 1040351-42-5 | Montelukast Cyclized Ether impurity;(E)-Montelukast Ether Impurity;7-chloro-2-[(E)-2-[3-(1,1-dimethyl-4,5-dihydro-3H-2-benzoxepin-3-yl)phenyl]ethenyl]quinoline | C29H26ClNO |
| 1040352-40-6 | D-arabino-2-Hexulosonic acid calcium salt hydrate (2:1:?) | Ca(C6H9O7)2.x(H2O) |
| 1040377-03-4 | 1-(Tetrahydropyran-4-yl)-1H-pyrazole-4-boronic acid pinacol ester;1-(Tetrahydropyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C14H23BN2O3 |
| 1040377-07-8 | 4-Bromo-1-(tetrahydro-3-furanyl)-1H-pyrazole | C7H9BrN2O |
| 1040377-08-9 | 1-(2-Hydroxyethyl)-1H-pyrazole-4-boronic acid pinacol ester;2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)pyrazol-1-yl]ethanol | C11H19BN2O3 |
| 1040377-12-5 | 4-(4-Bromo-2-pyridinyl)morpholine | C9H11BrN2O |
| 1040400-87-0 | (2-Amino-5-fluorophenyl)boronic acid | C6H7BFNO2 |
| 1040502-51-9 | 3-(Methylthio)-1H-indazole | C8H8N2S |
| 1040681-74-0 | 2-Fluoro-4-(trifluoromethyl)pyridine-3-carboxylic acid | C7H3F4NO2 |
| 1040682-68-5 | 1H-Pyrrolo[3,2-c]pyridine-4-carbonitrile | C8H5N3 |
| 1040682-84-5 | 1H-Pyrrolo[3,2-c]pyridine-4-carboxylic acid | C8H6N2O2 |
| 1040683-08-6 | Ethyl 1-(trifluoromethyl)cyclobutanecarboxylate | C8H11F3O2 |
| 1040745-70-7 | Potassium cyclopentyltrifluoroborate | C5H9BF3K |
| 1040848-01-8 | B-[4-(1H-Imidazol-2-yl)phenyl]boronic acid | C9H9BN2O2 |
| 1041026-55-4 | [3-Bromomethyl-1-(4-methylphenylsulfonyl)azetidin-3-yl]methanol | C12H16BrNO3S |
| 1041026-61-2 | 3,3-Bis(bromomethyl)-1-(4-tolylsulfonyl)azetidine | C12H15Br2NO2S |
| 1041026-70-3 | tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate;2,6-Diazaspiro[3.3]heptane-2-carboxylic acid 1,1-Dimethylethyl ester; ; 1,1-Dimethylethyl 2,6-diazaspiro[3.3]heptane-2-carboxylate; tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate | C10H18N2O2 |
| 1041026-71-4 | tert-Butyl 2,6-diazaspiro[3,3]heptane-2-carboxylate hemioxalate;2,6-Diazaspiro[3.3]heptane-2-carboxylic acid 1,1-dimethylethyl ester ethanedioate | 2(C10H18N2O2).C2H2O4 |
| 1041053-44-4 | 2-Oxazolemethanamine hydrochloride | C4H6N2O.HCl |
| 1041173-28-7 | (3S)-3-Morpholinecarboxylic acid methyl ester hydrobromide (1:1) | C6H11NO3.HBr |
| 1041186-22-4 | (1R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(triphenylsilyl)[1,1'-binaphthalene]-2,2'-diol | C56H50O2Si2 |
| 1041205-43-9 | 1-(Difluoromethyl)-4-iodo-1H-pyrazole | C4H3F2IN2 |
| 1041387-90-9 | N-[2-[(3,6-Diaminoacridin-9-yl)amino]ethyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide | C25H31N7O2S |
| 1041389-28-9 | (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfinyl)butyl]-3-isoquinolinecarboxamide | C32H45N3O5S |
| 1041421-77-5 | 3-(Pyridin-3-yl)-4H-furo[3,2-b]pyrrole-5-carboxylic acid | C12H8N2O3 |
| 1041423-26-0 | 1,3-Dichloro-6-fluoroisoquinoline | C9H4Cl2FN |
| 1041434-82-5 | Peramivir trihydrate;(1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic acid hydrate | C15H28N4O4.3(H2O) |
| 1041481-59-7 | 4-Fluoro-1H-indazole-5-carboxylic acid | C8H5FN2O2 |
| 1041642-13-0 | Potassium trifluoroisopropylborate | C3H7BF3.K |
| 1041766-91-9 | (3aS,4S,6aR)-N-[2-[2-[2-(2-Bromoethoxy)ethoxy]ethoxy]ethyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | C18H32BrN3O5S |
| 1042224-63-4 | Cyclopamine inhibitor 1;6-Imidazo[1,2-a]pyridin-3-yl-N-4-piperidinyl-2-pyridinamine | C17H19N5 |
| 1042224-77-0 | 4-[(6-Bromo-2-pyridinyl)amino]-1-piperidinecarboxylic acid tert-butyl ester | C15H22BrN3O2 |
| 1042330-85-7 | (1S,3aR,6aS)-Hexahydrocyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid 2-(1,1-dimethylethyl) 1-methyl ester | C14H23NO4 |
| 1042443-60-6 | [2-(Ethylsulfonyl)phenyl]boronic acid | C8H11BO4S |
| 1042672-97-8 | IRAK inhibitor 6;N-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide | C20H20N4O3S |
| 1042695-87-3 | (1R,2R,4S)-2-[(5-Hexen-1-ylmethylamino)carbonyl]-4-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]cyclopentanecarboxylic acid methyl ester | C32H41N3O5S |
| 1042777-99-0 | 5-[[2-(1-Pyrrolidinyl)ethyl]thio]-2-thiazolamine | C9H15N3S2 |
| 1042941-53-6 | 4,4''-Bis(diphenylamino)[1,1':4',1''-terphenyl]-2',5'-dicarboxaldehyde | C44H32N2O2 |
| 1043416-40-5 | 4-Fluoro-2-nitrobenzyl alcohol | C7H6FNO3 |
| 1043419-29-9 | 4-Bromo-3-pyridinecarboxylic acid methyl ester | C7H6BrNO2 |
| 1043500-82-8 | 4-Chloro-2-ethylbenzaldehyde | C9H9ClO |
| 1043567-32-3 | (11bS)-4-Hydroxy-2,6-di-9-phenanthrenyl-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C48H29O4P |
| 1043868-97-8 | 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine hydrochloride | C18H22INO3.HCl |
| 1043869-98-2 | 5-Fluoro-2-methoxypyridine-4-boronic acid | C6H7BFNO3 |